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GUEST EDITORIAL

End-of-Life Care: Crossing the Bridge
from Treatment to Support
With the aging population in the United
States projected to reach 83.7 million
by 2050, it is more important than ever
to ensure that sufficient resources and
services are available to support patientcentered palliative care. The quality and
costs of end-of-life care can be improved
through difficult but honest discussions,
shared decision-making and financial
reimbursement with incentives to support
implementation of advance care plans that
reflect patients’ wishes.1,2
Over the past four decades, our knowledge
regarding the aging process, extended
longevity, and end-of-life treatments has
expanded tremendously.1 The spectrum of
sophisticated diagnostics and innovative
procedures for managing illness and
delaying death have served to strengthen
the traditional medical paradigm of
paternalistic care in a death-averse society.
“[S]cientific advances have turned the
process of aging and dying into medical
experiences, matters to be managed
by healthcare professionals…and we…
have proved alarmingly unprepared for
it,” writes noted surgeon and author Dr.
Atul Gawande, who explores these issues
through professional practice, research,
and personal experiences in his recent
book, Being Mortal.2
There is national concern for the significant
costs—economic and otherwise—
associated with continued aggressive care
for serious and terminal illness to patients,
families and health systems. Research
and clinical evidence demonstrates the
value of engaging patients and families in
discussions about current clinical status,
treatment options, patient preferences,

and designation of surrogate decision
makers in advance care plans. To that
end, leading organizations, including the
National Quality Forum (NQF), the Institute
of Medicine (IOM), the American Society of
Clinical Oncology (ASCO), and the National
Hospice and Palliative Care Organization
(NHPCO) have identified advance care
practices (including integrated palliative
care) as major quality indicators associated
with good end-of-life care.
Treatment teams grapple with
incorporating objective quality measures,
due to complex and competing options,
which often arise during time-sensitive
situations. Clinicians are frequently
confronted with time constraints, as well
as uncertainty about treatment outcomes
and prognosis. This has led to repeat
hospitalizations and intensive care stays
associated with invasive services that are
of limited benefit, and delayed decisions
for transitions to supportive and comfort
care, prolonged suffering, diminished
quality of life and extended bereavement
for families.1,2 Additional challenges exist in
those situations where patients have not
communicated their preferences about
end-of-life care and support.2
Discussing end-of-life care where
prognoses are poor and recommended
treatment options are limited, uncertain,
or have been exhausted is difficult but
necessary for patients, families and
healthcare professionals.2 Clinicians have
reported a lack of experience broaching
these topics, a sense of incompetency
or failure to facilitate ‘better’ outcomes,
and emotions about our their mortality
as contributing factors.2 Dr. Susan D.

Block, a palliative care expert at the DanaFarber Cancer Institute and the Harvard
Medical School Center for Palliative Care,
recommends also asking patients about their
values and cultural beliefs; concerns about
what to expect; trade-offs they are willing
to make; how they want to spend their time
if their health worsens; who they want to
make decisions on their behalf if their health
worsens and end-of-life preferences.2,3,4
Over the course of illness, patients,
families and caregivers can assess and
revise care plans through shared decision
making. Patients may choose to decline
recommended treatments, seek alternative
treatments and/or discontinue all treatment
to achieve their best quality end-of-life. Key
decisions should be documented in advance
care plans, including legally executed
documents (e.g., health care proxy, durable
power of attorney, living will).
It is just as imperative to consider the
ethical issues inherent in end-of-life
planning as it is to address the clinical
challenges—both in training and practice.4
Clinicians must respect patients’ choices
and accept those decisions, even when
they conflict with their professional or
personal judgment about recommended
care and avoiding harm.2 While patients
may not have the medical expertise to
independently choose the most
appropriate treatment options, they have
the legal and ethical prerogative to define
what their highest quality of end of life will
be and when.
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